Happy Independence Day Weekend! As the firework shows wind down, we want to wrap up the week with three great contributor stories, and one research update. First, we have some…
According to The Seattle Times, the prognosis of a certain four-drug combination is much greater for patients with pancreatic cancer than the typical single standard cancer treatment. This discovery is…
According to a story from toweroncology.com, a recent study has revealed that a more aggressive chemotherapy could be significantly more effective for patients with pancreatic cancer after surgery in comparison…
According to a report by NBC news, despite seemingly endless advancements in cancer treatment, many experts agree that chemotherapy is still a powerful and valid tool. In fact, many see…
The US FDA has awarded Orphan Drug Designation to the experimental drug CPI-613, for the treatment of Burkitt lymphoma. The full article can be read here, at Globe Newswire. About…
According to a story by CBS News, an unsuspecting virus may become a potential treatment for brain cancer. The study showed that those who were given a genetically modified version…
Researchers have been studying an experimental treatment for cystic fibrosis that is thought to be effective regardless of a patient's genetics. The research is still in the early stages, but…
According to News Medical, a group of researchers at Johns Hopkins and the Bloomberg-Kimmel Institute for Cancer Immunotherapy recently found encouraging results for a study involving immunotherapy to treat a…
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
